Published in:
01-12-2020 | Insulins | Correction
Correction to: Microencapsulation of cellular aggregates composed of differentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue
Published in: Diabetology & Metabolic Syndrome | Issue 1/2020
Login to get accessExcerpt
Following publication of the original article [1], the authors identified an error in the caption of Fig. 2 and the in-text citation of Fig. 2. The error was that the descriptions for panel b and c were swapped.
Fig. 2
Expression of differentiation markers in hASC, IPC and GPC by indirect immunofluorescence. The images shown are representative of n = 3 experiments, visualized by confocal microscopy. Nuclear staining was performed with Hoechst 1: 500 (blue). Markers analyzed were Pdx1 (red), Ngn3 (green), Insulin (green), Glucagon (red), CD44 (green) and Vimentin (green). a Markers analyzed in hASC. b Markers analyzed in GPC. c Markers analyzed in IPC. Scale bar = 20 μm. Pdx1 pancreatic and duodenal homeobox 1, Ngn3 neurogenin 3, Ins insulin, Gcg glucagon, Vim vimentin
× ![]()
…